A message from Andreas Reif |
ECNP President Andreas Reif invites you to join us in Munich this October for the 39th ECNP Congress 2026. Discover the latest advances in applied neuroscience, connect with colleagues from around the world, and experience the unique ECNP atmosphere—from inspiring plenaries to our renowned Campfire Sessions. |
|
|
Heading to the 39th ECNP Congress 2026 in Munich, Germany? Booking through our trusted housing partner, c’accommodation (trademark of Colloquium Brussels). C’accommodation is the only agency offering the official congress rates. |
|
|
Roadmap Meeting on Precision Psychiatry |
From signals to stratification |
25–26 January 2027 | Amsterdam, The Netherlands, & virtually Join leading world experts from the research, industry, regulation, healthcare, and patient communities to explore the transition toward precision psychiatry in clinical trials. The meeting will address how biological mechanisms, patient stratification, AI-driven target identification, and evolving trial designs can advance clinically meaningful, interpretable, and regulatory-ready mental healthcare. |
|
|
Psychedelics are re-emerging as a promising area of mental health research. Explore the science behind their therapeutic potential with this new Course, designed for clinicians, researchers and trainees.
💠 Learn about mechanisms, evidence and the future of psychedelic therapies
💠 Registration is free with a myECNP account
💠 First lectures available from 14 September 2026 |
|
|
ECNP Early Career Workshop |
Only 100 places available! Are you an Early Career Scientist in Europe? Apply to present your poster on translation neuroscience at the ECNP Early Career Workshop, 18–21 March 2027 in Nice, France. Enjoy three days of expert lectures, dynamic discussions, and interactive poster sessions. Registration and accommodation are fully funded. |
|
|
Pharmacogenomics webinar series |
GLP-1 agonists in psychiatry |
Join Vincenzo Oliva, Spain, on 24 July 2026 at 16.00 CEST to explore the latest evidence on the potential of GLP-1 receptor agonists in psychiatric care, from mood disorders to cognitive symptoms and metabolic health. |
|
|
Unauthorised agencies and websites are falsely offering registration and accommodation services for the 39th ECNP Congress 2026, Munich, Germany. Only trust these websites:
➡️ www.ecnp.eu
➡️ www.ecnp.eu/congress2026
➡️ https://booking.accommodationbooking.eu/en/26ECNP/1 (for hotel booking) |
|
|
|
|
|
|